Krampera, M <br/><br/>
Early decrease of interferon-gamma+ and interleukin-2+ T cells during combination treatment with interferon-alpha and ribavirin in patients with chronic hepatitis C.  [electronic resource] 

 -  The American journal of gastroenterology  Dec 2000 
 - 3670-3 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't; Comment 
<br/><br/><label>ISSN: </label>0002-9270 
<br/><br/><label>Standard No.: </label>10.1111/j.1572-0241.2000.03413.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antiviral Agents--therapeutic use<br/>CD4-Positive T-Lymphocytes--immunology<br/>CD8-Positive T-Lymphocytes--immunology<br/>Case-Control Studies<br/>Drug Therapy, Combination<br/>Female<br/>Hepatitis C, Chronic--blood<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--therapeutic use<br/>Interferon-gamma--immunology<br/>Interleukin-2--immunology<br/>Male<br/>Middle Aged<br/>Recombinant Proteins<br/>Ribavirin--therapeutic use<br/>T-Lymphocyte Subsets--immunology<br/>Time Factors